CCL20 and COVID-19: Notably, the BAL from patients with ARDS or COVID-19 exhibited elevated levels of CCL2/MCP-1 and CCL20/MIP-3α (44–46), and research in the context of cancer has demonstrated the migration of NKT cells via these chemokines (47, 48).